US 11802131
Glutarimides for medical treatment
granted A61KA61K31/4412A61K31/4709
Quick answer
US patent 11802131 (Glutarimides for medical treatment) held by C4 THERAPEUTICS, INC. expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/4412, A61K31/4709, A61K31/498, A61K47/55